Bacterial membrane nanovesicles encapsulating prodrug assemblies combine chemical and immunological therapies for chronic bacterial infection.

During the 24-h observation period, a decreasing trend in bioluminescence intensity at the infection site was observed in mice treated with free Cip, but notably, C p E@BMV treatment resulted in a significant and rapid decrease in bioluminescence intensity at the infection site (Fig. 7b ).

also in 47,180 other papers